Thus, to test for relationships between K17 expression the tumor inflammatory microenvironment, we analyzed intratumoral and peritumoral CD8+ T cells, CD4+ T cells, CD16+/CD163− tumor-targeting (M1) macrophages and CD16+/CD163+ tumor promoting (M2) immune cells ratios across all cases. The gene discussed is CD163; the disease is neoplasm.